• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于在体内检测益生菌微生物大肠杆菌Nissle 1917菌株(EcN)的绿色荧光蛋白。

Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo.

作者信息

Schultz Michael, Watzl Sonja, Oelschlaeger Tobias A, Rath Heiko C, Göttl Claudia, Lehn Norbert, Schölmerich Jürgen, Linde Hans-Jörg

机构信息

Department of Internal Medicine I, University of Regensburg, Regensburg, Germany.

出版信息

J Microbiol Methods. 2005 Jun;61(3):389-98. doi: 10.1016/j.mimet.2005.01.007.

DOI:10.1016/j.mimet.2005.01.007
PMID:15767015
Abstract

Probiotic microorganisms are defined as viable nutritional agents conferring benefit to the health of the human host. Especially, Escherichia coli strain Nissle 1917 (EcN) was shown to be equally effective as mesalazine in the maintenance of remission in ulcerative colitis (UC). Presumably, the therapeutic effect of EcN is linked to the presence of the strain in the region of interest; however, it remains difficult to follow the orally administered strain on its passage through the complex microbial environment of the intestine in vivo, inhabited dominantly by various E. coli strains, using traditional culturing methods. In this study we transformed EcN and a wild-type E. coli from a laboratory rat (EcR) with a plasmid carrying a gfp gene (pUC-gfp) to obtain EcN- and EcR-GFP to allow in vivo detection without alteration of strain-specific characteristics. Analysis of different strain-specific characteristics included the measurement of stimulation of IL-8 secretion and adhesion in vitro using the epithelial cell line HT-29. The kinetics of intestinal distribution in mice and colonization properties in rats following oral administration was studied in vivo. Detectability of the strain in histologic specimens was analysed using fluorescence microscopy and immunohistochemistry. The identity of fluorescent E. coli strains isolated from stool samples, Peyer's patches (PP) and mesenteric lymph nodes (MLN) was determined by REP-PCR. We were able to demonstrate that EcN and EcN-GFP do not differ in stimulation of IL-8 secretion or adhesion to HT-29 cells. In vivo, EcN-GFP colonies were readily detectable by fluorescence microscopy in luminal samples and also by immunohistochemistry in histological sections allowing analysis of the kinetics of the intestinal passage following oral administration. Translocation of fluorescent and non-fluorescent bacteria into PP and MLN was noted at 6 h post oral administration. EcN-GFP was detectable initially for 14 days in faecal samples of rats, while EcR-GFP was detectable throughout the whole experiment (45 days). Challenge with ampicillin at day 45 demonstrated continuing presence of EcN-GFP in small numbers by reappearing fluorescent colonies. The plasmid was not stable in vivo since non-fluorescent EcN colonies were detected also in faecal samples by REP-PCR. In summary, transformation of EcN to obtain EcN-GFP in our study had no detectable influence on the probiotic microorganism regarding adhesion on and induction of IL-8 secretion of HT-29 cells and allows the detection in mixed microbial environments in vivo but the stability of EcN-GFP in vivo is limited.

摘要

益生菌被定义为对人类宿主健康有益的活营养剂。特别是,大肠杆菌菌株Nissle 1917(EcN)在维持溃疡性结肠炎(UC)缓解方面显示出与美沙拉嗪同样有效。据推测,EcN的治疗效果与其在感兴趣区域的存在有关;然而,使用传统培养方法,很难在体内追踪口服给药的菌株在通过由各种大肠杆菌菌株主导的复杂肠道微生物环境时的情况。在本研究中,我们用携带绿色荧光蛋白基因(pUC - gfp)的质粒转化EcN和来自实验室大鼠的野生型大肠杆菌(EcR),以获得EcN - GFP和EcR - GFP,以便在不改变菌株特异性特征的情况下进行体内检测。对不同菌株特异性特征的分析包括使用上皮细胞系HT - 29测量体外IL - 8分泌刺激和黏附情况。在体内研究了口服给药后小鼠肠道分布动力学和大鼠的定植特性。使用荧光显微镜和免疫组织化学分析组织学标本中菌株的可检测性。通过REP - PCR确定从粪便样本、派尔集合淋巴结(PP)和肠系膜淋巴结(MLN)分离的荧光大肠杆菌菌株的身份。我们能够证明EcN和EcN - GFP在刺激IL - 8分泌或黏附于HT - 29细胞方面没有差异。在体内,通过荧光显微镜在管腔样本中很容易检测到EcN - GFP菌落,在组织学切片中也可通过免疫组织化学检测到,从而可以分析口服给药后肠道通过的动力学情况。口服给药后6小时,观察到荧光和非荧光细菌向PP和MLN的易位。EcN - GFP最初在大鼠粪便样本中可检测14天,而EcR - GFP在整个实验期间(45天)均可检测到。在第45天用氨苄青霉素进行挑战,通过再次出现荧光菌落证明仍有少量EcN - GFP持续存在。由于通过REP - PCR在粪便样本中也检测到了非荧光EcN菌落,所以该质粒在体内不稳定。总之,在我们的研究中,将EcN转化为EcN - GFP对益生菌在黏附于HT - 29细胞和诱导其IL - 8分泌方面没有可检测到的影响,并允许在体内混合微生物环境中进行检测,但EcN - GFP在体内的稳定性有限。

相似文献

1
Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo.用于在体内检测益生菌微生物大肠杆菌Nissle 1917菌株(EcN)的绿色荧光蛋白。
J Microbiol Methods. 2005 Jun;61(3):389-98. doi: 10.1016/j.mimet.2005.01.007.
2
Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88.用表达菌毛黏附素K88的重组大肠杆菌Nissle 1917对小鼠进行口服疫苗接种后的免疫反应分裂
Int J Med Microbiol. 2009 Nov;299(7):467-78. doi: 10.1016/j.ijmm.2009.03.003. Epub 2009 May 20.
3
Escherichia coli Nissle 1917 for probiotic use in piglets: evidence for intestinal colonization.大肠杆菌 Nissle 1917 用于仔猪的益生菌用途:肠道定植的证据。
J Appl Microbiol. 2009 Nov;107(5):1697-710. doi: 10.1111/j.1365-2672.2009.04361.x. Epub 2009 May 20.
4
Detection and distribution of probiotic Escherichia coli Nissle 1917 clones in swine herds in Germany.德国猪群中益生菌大肠杆菌Nissle 1917克隆株的检测与分布
J Appl Microbiol. 2006 Dec;101(6):1357-66. doi: 10.1111/j.1365-2672.2006.03019.x.
5
Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair.大肠杆菌Nissle 1917益生菌作用的分子机制涉及ZO-2和PKCζ的重新分布,从而导致紧密连接和上皮屏障修复。
Cell Microbiol. 2007 Mar;9(3):804-16. doi: 10.1111/j.1462-5822.2006.00836.x. Epub 2006 Nov 3.
6
Intestinal immunity of Escherichia coli NISSLE 1917: a safe carrier for therapeutic molecules.大肠杆菌NISSLE 1917的肠道免疫:治疗性分子的安全载体
FEMS Immunol Med Microbiol. 2005 Mar 1;43(3):373-84. doi: 10.1016/j.femsim.2004.10.023.
7
Effect of orally administered probiotic E. coli strain Nissle 1917 on intestinal mucosal immune cells of healthy young pigs.口服益生菌大肠杆菌菌株Nissle 1917对健康幼猪肠道黏膜免疫细胞的影响。
Vet Immunol Immunopathol. 2006 Jun 15;111(3-4):239-50. doi: 10.1016/j.vetimm.2006.01.017. Epub 2006 Mar 13.
8
Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis.大肠杆菌Nissle 1917对两种不同小鼠结肠炎模型急性和慢性肠道炎症的预防作用
Clin Diagn Lab Immunol. 2004 Mar;11(2):372-8. doi: 10.1128/cdli.11.2.372-378.2004.
9
Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study.用于儿童和青少年溃疡性结肠炎缓解期维持治疗的益生菌大肠杆菌Nissle 1917(EcN):一项开放标签的试点研究。
Z Gastroenterol. 2008 Sep;46(9):874-5. doi: 10.1055/s-2008-1027463. Epub 2008 Sep 22.
10
Probiotic Escherichia coli Nissle 1917 activates DC and prevents house dust mite allergy through a TLR4-dependent pathway.益生菌大肠杆菌 Nissle 1917 通过 TLR4 依赖性途径激活 DC 并预防屋尘螨过敏。
Eur J Immunol. 2010 Jul;40(7):1995-2005. doi: 10.1002/eji.200939913.

引用本文的文献

1
Innovative applications and research advances of bacterial biosensors in medicine.细菌生物传感器在医学中的创新应用与研究进展
Front Microbiol. 2025 Apr 23;16:1507491. doi: 10.3389/fmicb.2025.1507491. eCollection 2025.
2
Gut Microbiota-Based Immunotherapy: Engineered Nissle 1917 for Oral Delivery of Glypican-1 in Pancreatic Cancer.基于肠道微生物群的免疫疗法:工程化的1917株大肠杆菌用于胰腺癌中Glypican-1的口服递送
Medicina (Kaunas). 2025 Mar 30;61(4):633. doi: 10.3390/medicina61040633.
3
Engineering the Escherichia coli Nissle strain for monitoring the bacterial cell distribution and therapeutic protein expression within the intestinal tract of animal models.
对大肠杆菌Nissle菌株进行工程改造,以监测动物模型肠道内的细菌细胞分布和治疗性蛋白质表达。
Biotechnol Lett. 2025 Apr 12;47(2):41. doi: 10.1007/s10529-025-03586-4.
4
Advancements in fluorescent labeling in assessing the probiotic adhesion capacity - A review.荧光标记在评估益生菌黏附能力方面的进展——综述
World J Microbiol Biotechnol. 2025 Feb 27;41(3):73. doi: 10.1007/s11274-024-04186-6.
5
Towards Understanding Tumour Colonisation by Probiotic Bacterium Nissle 1917.深入了解益生菌Nissle 1917对肿瘤的定殖作用
Cancers (Basel). 2024 Aug 26;16(17):2971. doi: 10.3390/cancers16172971.
6
Advances in Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies.Nissle 1917作为用于疾病治疗和诊断策略的可定制药物递送系统的研究进展。
Mater Today Bio. 2023 Jan 6;18:100543. doi: 10.1016/j.mtbio.2023.100543. eCollection 2023 Feb.
7
Nissle 1917 as a Novel Microrobot for Tumor-Targeted Imaging and Therapy.Nissle 1917作为一种用于肿瘤靶向成像和治疗的新型微型机器人。
Pharmaceutics. 2021 Aug 9;13(8):1226. doi: 10.3390/pharmaceutics13081226.
8
Plasmid Vectors for Selection-Free Use with the Probiotic Nissle 1917.用于无选择使用益生菌 1917 的质粒载体。
ACS Synth Biol. 2021 Jan 15;10(1):94-106. doi: 10.1021/acssynbio.0c00466. Epub 2020 Dec 10.
9
Beneficial effects of Lactobacillus reuteri 6475 on bone density in male mice is dependent on lymphocytes.罗伊氏乳杆菌 6475 对雄性小鼠骨密度的有益作用依赖于淋巴细胞。
Sci Rep. 2019 Oct 11;9(1):14708. doi: 10.1038/s41598-019-51293-8.
10
Development of Cell-Based Sentinels for Nitric Oxide: Ensuring Marker Expression and Unimodality.基于细胞的一氧化氮哨兵的开发:确保标记物表达和单峰性。
ACS Synth Biol. 2018 Jul 20;7(7):1694-1701. doi: 10.1021/acssynbio.8b00146. Epub 2018 Jul 9.